Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hricak, H.
Right arrow Articles by Arenson, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hricak, H.
Right arrow Articles by Arenson, R. L.

Radiology, Vol 198, 403-409, Copyright © 1996 by Radiological Society of North America


ARTICLES

Invasive cervical carcinoma: role of MR imaging in pretreatment work-up- -cost minimization and diagnostic efficacy analysis

H Hricak, CB Powell, KK Yu, E Washington, LL Subak, JL Stern, MG Cisternas and RL Arenson
Department of Radiology, University of California, San Francisco 94143- 0628, USA.

PURPOSE: To examine the cost and efficacy of diagnostic work-up in patients with invasive cervical cancer. MATERIALS AND METHODS: In 246 patients with invasive cervical cancer, all diagnostic tests performed before treatment were recorded. Patients were divided into two groups: those who underwent magnetic resonance (MR) imaging as the initial study (n = 105) and those who did not (n = 141). A list of 1995 Medicare global payments was used to measure cost. Bayesian analysis (likelihood ratios derived from a literature search) was performed for bladder, rectal, parameterial, and nodal involvement in stage Ib disease. RESULTS: Significantly fewer procedures and fewer invasive studies were performed in the MR imaging group. Net cost savings for the MR imaging group was $401 for all patients and $449 for patients with stage Ib disease. For stage Ib disease, the 0% pretest probability of bladder or rectal invasion does not justify the routine use of barium enema examination, cystoscopy, or proctoscopy. The increase in predictive values for parameterial and nodal disease was highest for MR imaging when tumor size was at least 2 cm. CONCLUSION: Guidelines for the pretreatment work-up of clinical stage Ib cervical cancer need revision. MR imaging should be used as an adjunct to clinical evaluation.


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
E. Sala, S. Wakely, E. Senior, and D. Lomas
MRI of Malignant Neoplasms of the Uterine Corpus and Cervix
Am. J. Roentgenol., June 1, 2007; 188(6): 1577 - 1587.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. G. Mitchell, B. Snyder, F. Coakley, C. Reinhold, G. Thomas, M. Amendola, L. H. Schwartz, P. Woodward, H. Pannu, and H. Hricak
Early Invasive Cervical Cancer: Tumor Delineation by Magnetic Resonance Imaging, Computed Tomography, and Clinical Examination, Verified by Pathologic Results, in the ACRIN 6651/GOG 183 Intergroup Study
J. Clin. Oncol., December 20, 2006; 24(36): 5687 - 5694.
[Abstract] [Full Text] [PDF]


Home page
ImagingHome page
C Lopez and S Chakravarti
Imaging of cervical cancer
Imaging, August 1, 2006; 18(1): 10 - 19.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
D. H. Moore
Cervical Cancer
Obstet. Gynecol., May 1, 2006; 107(5): 1152 - 1161.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. Sironi, A. Buda, M. Picchio, P. Perego, R. Moreni, A. Pellegrino, M. Colombo, C. Mangioni, C. Messa, and F. Fazio
Lymph Node Metastasis in Patients with Clinical Early-Stage Cervical Cancer: Detection with Integrated FDG PET/CT
Radiology, December 1, 2005; 238(1): 272 - 279.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. E. Singer and K. E. Applegate
Cost-Effectiveness Analysis in Radiology
Radiology, June 1, 2001; 219(3): 611 - 620.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
W. T. Yang, W. W. M. Lam, M. Y. Yu, T. H. Cheung, and C. Metreweli
Comparison of Dynamic Helical CT and Dynamic MR Imaging in the Evaluation of Pelvic Lymph Nodes in Cervical Carcinoma
Am. J. Roentgenol., September 1, 2000; 175(3): 759 - 766.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
A. R. Margulis and J. H. Sunshine
Radiology at the Turn of the Millennium1
Radiology, January 1, 2000; 214(1): 15 - 23.
[Abstract] [Full Text]


Home page
RadiologyHome page
L. Van Hoe, D. Vanbeckevoort, R. Oyen, U. Itzlinger, and I. Vergote
Cervical Carcinoma: Optimized Local Staging with Intravaginal Contrast- enhanced MR Imaging- Preliminary Results
Radiology, October 1, 1999; 213(2): 608 - 611.
[Abstract] [Full Text]


Home page
RadiologyHome page
E. S. Siegelman and E. K. Outwater
Tissue Characterization in the Female Pelvis by Means of MR Imaging
Radiology, July 1, 1999; 212(1): 5 - 18.
[Abstract] [Full Text]


Home page
RadiologyHome page
S. Postema, P. M. T. Pattynama, C. S. P. van Rijswijk, and J. B. Trimbos
Cervical Carcinoma: Can Dynamic Contrast-enhanced MR Imaging Help Predict Tumor Aggressiveness?
Radiology, January 1, 1999; 210(1): 217 - 220.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1996 by the Radiological Society of North America.